We are live on
!
Find out more
CIM
Contravisory Investment Management Portfolio holdings
AUM
$566M
1-Year Est. Return
42.93%
This Fund
S&P 500
This Quarter
Est. Return
-0.89%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$460M
AUM Growth
-$38.6M
(-7.7%)
Cap. Flow
-$29.6M
Cap. Flow
% of AUM
-6.45%
Top 10 Holdings %
Top 10 Hldgs %
32.51%
Holding
204
New
45
Increased
6
Reduced
49
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$11M |
| 2 |
HCA Healthcare
HCA
|
+$10.4M |
| 3 |
CMS Energy
CMS
|
+$9.3M |
| 4 |
Tapestry
TPR
|
+$8.94M |
| 5 |
Dick's Sporting Goods
DKS
|
+$8.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HSP
HOSPIRA INC
HSP
|
+$19.8M |
| 2 |
Entergy
ETR
|
+$11.6M |
| 3 |
Baidu
BIDU
|
+$11.2M |
| 4 |
Norfolk Southern
NSC
|
+$11M |
| 5 |
HP
HPQ
|
+$10.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.77% |
| 2 | Consumer Staples | 16.59% |
| 3 | Technology | 10.76% |
| 4 | Real Estate | 8.83% |
| 5 | Industrials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$161B
| $22M | 4.79% |
188,144
-15,183
| -7% | -$1.66M |
|
2
Humana
HUM
$46.7B
| $17.3M | 3.77% |
90,513
-9,690
| -10% | -$1.8M |
|
3
Moody's
MCO
$81.7B
| $17.1M | 3.71% |
157,983
-14,829
| -9% | -$1.6M |
|
4
Cintas
CTAS
$82.4B
| $15.3M | 3.33% |
722,924
-59,884
| -8% | -$1.26M |
|
5
CVS Health
CVS
$137B
| $15.2M | 3.3% |
144,670
-10,919
| -7% | -$1.12M |
|
6
Amgen
AMGN
$203B
| $14M | 3.05% |
91,390
-7,020
| -7% | -$1.12M |
|
7
Ashland
ASH
$3.04B
| $13.2M | 2.86% |
220,654
-17,225
| -7% | -$1.07M |
|
8
International Flavors & Fragrances
IFF
$19.4B
| $11.9M | 2.6% |
109,341
-7,153
| -6% | -$826K |
|
|
9
HCA Healthcare
HCA
$84.8B
| $11.7M | 2.56% |
+129,505
| New | +$10.4M |
|
10
McKesson
MCK
$98.5B
| $11.7M | 2.54% |
51,957
-3,113
| -6% | -$720K |
|
|
BRCM
11
DELISTED
BROADCOM CORP CL-A
BRCM
| $11.6M | 2.53% |
+226,030
| New | +$11M |
|
12
AB InBev
BUD
$158B
| $11.5M | 2.49% |
94,933
-5,940
| -6% | -$729K |
|
13
Check Point Software Technologies
CHKP
$13.3B
| $11.3M | 2.46% |
141,872
-10,551
| -7% | -$892K |
|
14
Equity Residential
EQR
$25.4B
| $10.9M | 2.38% |
155,819
-11,193
| -7% | -$831K |
|
15
Archer Daniels Midland
ADM
$41.4B
| $10.9M | 2.37% |
225,960
-16,392
| -7% | -$827K |
|
16
F5
FFIV
$22.1B
| $10.9M | 2.37% |
90,520
-5,211
| -5% | -$641K |
|
|
HDS
17
DELISTED
HD Supply Holdings, Inc.
HDS
| $10.8M | 2.35% |
306,966
-25,768
| -8% | -$856K |
|
18
Boston Properties
BXP
$11B
| $10.6M | 2.31% |
87,892
-5,143
| -6% | -$678K |
|
19
TE Connectivity
TEL
$58.8B
| $10.6M | 2.31% |
165,008
-9,650
| -6% | -$667K |
|
20
3M
MMM
$89B
| $10.5M | 2.28% |
81,370
-4,952
| -6% | -$664K |
|
|
BNY
21
Bank of New York Mellon
BNY
$108B
| $10.4M | 2.27% |
248,975
-13,525
| -5% | -$576K |
|
22
Merck
MRK
$324B
| $10.3M | 2.25% |
190,056
-10,068
| -5% | -$565K |
|
23
Ingredion
INGR
$6.38B
| $10.3M | 2.24% |
128,914
-9,383
| -7% | -$754K |
|
|
MJN
24
DELISTED
Mead Johnson Nutrition Company
MJN
| $10.2M | 2.23% |
113,566
-8,466
| -7% | -$816K |
|
25
Johnson & Johnson
JNJ
$635B
| $10.1M | 2.2% |
103,567
-5,372
| -5% | -$538K |
|
Similar funds
FG
SAM
BCMLT
KJWM
PAM
PEP
OC
LC
Contravisory Investment Management's Q2 2015 Portfolio in Review
As of Q2 2015, Contravisory Investment Management held 204 positions worth $460M, down 7.7% from $498M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Contravisory Investment Management withdrew a net $29.6M in Q2 2015, closing 33 positions and reducing 49 holdings. Its most notable exit was HOSPIRA INC, an estimated $19.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, Contravisory Investment Management opened a new position in BROADCOM CORP CL-A worth $11.6M.
- Contravisory Investment Management's largest Q2 2015 buy was BROADCOM CORP CL-A: 226,030 shares worth $11.6M.
- Contravisory Investment Management added most to Shire pic in Q2 2015, an estimated $19.1K increase.
- Contravisory Investment Management's biggest Q2 2015 reduction was Entergy, cutting an estimated $11.6M.
- Contravisory Investment Management fully exited HOSPIRA INC in Q2 2015, selling an estimated $19.8M.
- Contravisory Investment Management's ten largest holdings make up 33% of its $460M portfolio in Q2 2015.
- Contravisory Investment Management opened 45 new positions and closed 33 in Q2 2015.
- Contravisory Investment Management's portfolio value fell 7.7% quarter-over-quarter to $460M.
Based on Contravisory Investment Management's 13F filing for Q2 2015, filed 9 Jul 2015.